Why does my body smell like fish?

If your body has a fishy odour that persists despite thorough washing, there is a biochemical explanation, and it is not a matter of hygiene. The molecule most commonly responsible is trimethylamine, usually shortened to TMA. It is produced when bacteria in your gut break down certain nutrients from food, and it leaves the body through sweat, breath, and urine. When the smell is persistent, the underlying condition is called trimethylaminuria (TMAU), sometimes referred to as fish-odour syndrome.

Many people who live with TMAU find the term "fish-odour syndrome" derogatory and prefer "trimethylaminuria"; that is the term this article uses.^[10] The condition is real, it is measurable in a laboratory, and it carries a genuine psychosocial burden. It is also frequently misunderstood, including by clinicians, which is part of why a clear explanation of the science matters.

This article explains what TMA is, how your body normally clears it, what goes wrong in trimethylaminuria, how it is diagnosed, and what the peer-reviewed evidence says about managing it. The claims here are grounded in published research. Where the science is still emerging, that is stated explicitly. Crucially, there is no cure at present.^[1]

1. The molecule behind the smell: trimethylamine

Trimethylamine is a small nitrogen-containing compound with an intense, unmistakably fishy odour. The human nose detects it at very low concentrations, so even trace amounts reaching the skin surface can produce a perceptible smell. It is the same compound responsible for the smell of fish that is no longer fresh.

One property of TMA is central to everything that follows: it is a weak base, which means its tendency to escape into the air as a smell depends on the acidity of its surroundings. In acidic conditions, TMA holds on to a hydrogen ion and exists as a non-volatile salt that stays put and produces little odour. In alkaline conditions, that hydrogen ion is released, TMA reverts to its free volatile form, and the fishy smell is liberated. This is why low-pH cleansers have long been used to reduce the odour: lowering the pH at the skin surface keeps TMA in its trapped, non-volatile form.^[1][2] Hold on to this point, because it determines which surface products can help and which make the problem worse.

2. How your body makes and clears TMA

TMA does not come directly from food. It is produced by gut bacteria from dietary building blocks, chiefly choline, carnitine, and lecithin, along with trimethylamine N-oxide (TMAO) that is present in food. The richest dietary sources of these precursors are marine fish and other seafood, eggs, liver and other offal, legumes such as beans and peas, and lecithin-containing foods. Certain vegetables in the brassica family (such as cabbage, broccoli, Brussels sprouts, and cauliflower) also affect the pathway.^[2][1]

Once gut bacteria release TMA, it is absorbed from the intestine into the bloodstream and carried to the liver. There, an enzyme called flavin-containing monooxygenase 3, abbreviated FMO3, oxidises TMA into TMAO. TMAO is odourless and water-soluble, and it is excreted harmlessly in the urine.^[1][2]

Laboratories express how well this system is working as a metabolic capacity: the proportion of total trimethylamine that has been converted to the odourless oxide, calculated as TMAO divided by the sum of TMA and TMAO. In people without the condition, this figure is above 95%, meaning almost all the TMA is being oxidised. When FMO3 cannot keep pace with the amount of TMA arriving, the proportion falls, free TMA accumulates, and the excess is excreted through sweat, breath, and urine, carrying its fishy odour with it.^[6][7]

3. Primary and secondary trimethylaminuria

Trimethylaminuria comes in two broad forms, and the distinction guides both diagnosis and management.

Primary (inherited) trimethylaminuria

The primary form is genetic. It is caused by inherited variants in the FMO3 gene that reduce the enzyme's ability to oxidise TMA. This gene sits on the long arm of chromosome 1, at position 1q24.3, and is read from nine coding segments called exons.^[1] It is inherited in an autosomal recessive pattern, which typically means a person carries two altered copies of the gene, one from each parent.^[2] More than 300 variants of the gene have been described, and over 90 have been linked to trimethylaminuria.^[1]

The severe inherited form is estimated to affect roughly 1 in 40,000 people, though wider figures for the condition as a whole range from about 1 in 200,000 to 1 in 1,000,000 depending on the population and the definition used.^[1][3] Carrier frequency, meaning people with a single altered copy, is around 0.5 to 1% in white British populations and considerably higher in some others, reported at around 11% in one New Guinean population.^[1][2]

Not everyone with symptoms carries two classic disease-causing mutations. Certain combinations of milder genetic variants, such as the E158K and E308G changes when inherited together, can lower FMO3 capacity enough to produce a mild but genuine odour, particularly under dietary or hormonal stress.^[1] This is one reason a person can smell the odour intermittently yet have unremarkable results on a basic genetic screen.

Secondary (acquired) trimethylaminuria

The secondary form arises when the FMO3 enzyme is fundamentally intact but is overwhelmed or impaired by circumstances. Recognised causes include an excessive dietary load of precursors, such as very high choline intake; liver or kidney disease that reduces the body's processing and clearance capacity; the transient trimethylaminuria sometimes seen in young children and in premature infants whose enzyme systems are still maturing; and hormonal changes, with some women noticing the odour worsen around menstruation.^[2][3][4] A shift in the balance of gut bacteria toward species that produce more TMA has also been proposed as a contributor to the secondary form, though this specific mechanism remains a hypothesis rather than an established fact.^[13]

Because the secondary form has an external driver, addressing that driver can resolve it. In documented cases, closing an abnormal blood vessel called a congenital portosystemic shunt, which had been allowing blood to bypass the liver, resolved the associated trimethylaminuria.^[3] This is the clearest illustration of the central principle of this article: when the internal source is corrected, the odour follows.

4. Why the odour comes and goes

One of the most confusing features of trimethylaminuria is that the odour is often intermittent. It can be strong on one day and undetectable on another, which leads some people, and some doctors, to doubt it is real. The biochemistry explains the pattern.

The odour tracks the load of precursors passing through the gut. A meal rich in choline, carnitine, or TMAO gives gut bacteria more raw material, produces more TMA, and can overwhelm a limited FMO3 capacity for a period afterward. This was demonstrated directly in a study at the Monell Chemical Senses Center: among people who tested positive for trimethylaminuria, only around 5% had a mild fishy odour detectable on the palms at baseline, and none were detectable at normal social distance before a dietary challenge. After a measured dose of choline, around 10% became detectable at social distance. A fishy odour was never noted in people who tested negative.^[8] In other words, the odour is real, it is frequently below social-distance detectability at rest, and it is provoked by precursor load.

Hormonal state also matters. In the same body of work, people who tested positive tended to show higher trimethylamine levels within about a week of menstruation, although the effect was marginal.^[8] Perimenstrual worsening has been described elsewhere as well, with reduced metabolic capacity recorded in some women during menstruation.^[6] This intermittency has a practical consequence for testing, discussed in the next section: a single sample taken on a low-odour day can miss the condition, and women are generally advised to avoid sampling around menstruation.^[7]

5. Getting a diagnosis

The single most important step is to get a proper diagnosis before assuming what the cause is, and before starting any restrictive diet. Trimethylaminuria is confirmed with a straightforward urine test.

The first-line test measures the ratio of TMA to TMAO in the urine, ideally after a standardised challenge that loads the system with precursors, such as two eggs and 400 grams of beans, or a fish load of around 300 grams of marine fish followed by urine collection over the next several hours.^[2][3] Laboratories grade the result by severity: broadly, a metabolic capacity below about 90% is consistent with trimethylaminuria, with lower percentages indicating more severe impairment.^[7] Genetic testing of the FMO3 gene can follow, and it gives its highest yield in severe cases; in one cohort, genetic confirmation was achieved in about 54% of those tested, with the best results in the most severely affected.^[7] Biochemical urine testing, in short, is the practical starting point.

When the test is negative: a note handled with care

Not everyone who perceives a persistent body odour has trimethylaminuria, and this needs to be said gently, because the distress is real either way. In a Canadian genetics clinic, 54 people were referred over several years for assessment of a suspected fishy or unusual body odour. On biochemical testing, only 2 of the 54 had confirmed trimethylaminuria. Around 83% were judged to have a pattern consistent with olfactory reference syndrome, a condition in which a person is preoccupied with an odour that others cannot detect.^[9] It is important to read that figure correctly: it describes a selected group already referred to a genetics clinic and assessed by chart review, not the general population, and it is not a verdict that anyone is imagining things. Olfactory reference syndrome is a recognised source of genuine suffering that deserves support in its own right.

There are some distinguishing features. Trimethylaminuria typically begins in childhood, whereas olfactory reference syndrome more often began in adulthood, at an average age of around 28 in that cohort.^[9] The direction of caution runs both ways, though: researchers at Monell noted that some people labelled with olfactory reference syndrome may in fact test positive for trimethylaminuria.^[8] The sensible course is the same in every case: get the urine test first. If it is positive, you have a clear path. If it is negative, you still deserve support, and a clinician can help you find the right one.

The burden is real, and diagnosis brings relief

The psychosocial weight of this condition is well documented and should not be minimised. In a UK survey of people living with trimethylaminuria, the great majority reported ostracism at work and in social settings, and every respondent reported some experience of bullying, harassment, or ostracism; the median age at which symptoms began was 19.^[10] In an Irish qualitative study, people described diagnostic delays ranging from years to decades and being dismissed by clinicians, followed by profound relief and validation once a diagnosis was finally made.^[11] Getting the test done is not only a medical step; for many people it is the beginning of being believed.

6. What the evidence says about management

The headline is simple: there is no cure. As a 2024 review put it, a definitive pharmacological treatment does not yet exist, and patients are offered only palliative treatments.^[1] Management works by reducing how much TMA the body produces and by reducing how much of it reaches the air. Every option below has a different strength of evidence, and they are presented in that order of certainty. All of them are best pursued under medical guidance.

Dietary modification

Reducing the intake of TMA precursors lowers the raw material available to gut bacteria. This means moderating foods rich in choline, TMAO, and lecithin, such as marine fish, eggs, offal, and legumes, and taking account of brassica vegetables that influence the enzyme.^[2][1] Because choline is an essential nutrient, dietary restriction should be guided by a doctor or registered dietitian to avoid deficiency, and this is especially important in children and during pregnancy.^[2]

Gut binders: activated charcoal and copper chlorophyllin

Two supplements aim to intercept TMA in the gut before it is absorbed. In a small open-label Japanese study, activated charcoal at 1.5 grams per day for 10 days lowered free urinary TMA and raised apparent metabolic capacity in the two people who took it, with the effect reversing after the supplement was stopped. Copper chlorophyllin at 180 milligrams per day for three weeks produced a similar improvement in three people, and the benefit persisted for some weeks after stopping.^[6] Comparable doses are described in clinical references, typically activated charcoal at 750 milligrams twice daily for 10 days and copper chlorophyllin at 60 milligrams three times daily for three weeks.^[2]

These figures should be read for what they are: small early evidence. The studies were open-label, with only a handful of participants, no placebo group, and a urinary chemical measure rather than a measurement of actual odour or quality of life. They show a signal worth taking seriously, and they should not be described as proven to stop the smell. Notably, the authors of that study recommended these supplements for use in combination with, and following, established treatments, and after consultation with the person's physician.^[6] The primary evidence itself frames them as physician-supervised adjuncts.

Riboflavin

Riboflavin, vitamin B2, is a cofactor for the FMO3 enzyme, and supplementing it is thought to help the residual enzyme work more efficiently in people who retain some function. Doses of around 30 to 40 milligrams taken three to five times daily are described.^[2] The direct treatment evidence is small and mixed: in one study using NMR spectroscopy, two children responded with clear falls in their TMA measures, while an adult did not respond and withdrew.^[5] Riboflavin may help, particularly where some enzyme activity remains, and it should not be presented as reliably effective.

Acid-pH skin washes

Because TMA is only volatile in its free, unprotonated form, lowering the pH at the skin surface keeps it in its trapped, non-volatile state and reduces the odour that escapes. Low-pH cleansers in the pH 5.5 to 6.5 range have been used on this principle.^[1][2] This is the one lever in the standard toolkit that acts at the skin itself, and it is the bridge to the surface-management section below.

Antibiotics

Short courses of gut-acting antibiotics such as metronidazole, neomycin, or rifaximin can reduce the bacterial production of TMA and provide temporary relief. Their effect is inconsistent between individuals, and because of the risks of resistance and disruption to the gut flora, they are used for short periods rather than as a standing treatment.^[1][2][3]

7. On the horizon

Several approaches are being studied that could change the picture in the future. It is important to be clear that none of these are proven treatments in humans, and none should be used as such today. They are included here so that the frontier is represented fairly.

8. The two-stage model: source and surface

Everything above points to a single organising idea. Trimethylaminuria is produced inside the body and expressed at the skin. Managing it well therefore takes two coordinated stages: a doctor addresses the internal source, and whatever escapes to the skin is managed at the surface. Neither stage substitutes for the other. A doctor calms the source; the surface handles the remainder.

Why deodorants do not reach this odour

Deodorants and antiperspirants were designed for a different problem: surface-level bacteria in the underarm and other body parts breaking down sweat to produce sour or onion-like odours. They work by reducing those surface bacteria. Trimethylamine is a different kind of problem. It arrives at the skin through the bloodstream, it can surface anywhere on the body rather than only in the armpits, and it is a small volatile amine whose behaviour is governed by pH. Reducing skin bacteria does not address a molecule the skin bacteria are not producing.

Two surface levers that match TMA's chemistry

Two mechanisms at the skin surface are matched to what TMA actually is. The first is acid pH. As established earlier, TMA is only volatile in its free form, so holding the skin surface at an acidic pH keeps it in its protonated, non-volatile state, which is the same principle behind the low-pH cleansers described in the clinical literature.^[1][2] The second is molecular trapping: certain compounds have cage-like structures with internal cavities sized to physically enclose small molecules such as TMA, forming a stable complex that prevents the molecule from escaping into the air. The Volatile Control System is built around both of these mechanisms working together, an acid-managed surface combined with molecular trapping selected for small amine molecules.

There is one more consequence of the biology. Because TMA reaches the skin through the bloodstream, it surfaces across the whole body, not only the underarms. An underarm-only product, however well designed, covers a fraction of the area involved. The surface stage for this pathway calls for whole-body coverage: an acid-managed wash and molecular trapping applied across the skin, rather than a single spot treatment.

The limit of surface management

The surface stage has a ceiling, and it is important to state it plainly. Surface management can only address the portion of the odour that reaches the skin. If the Volatile Control System cannot reduce a given smell, no other topical product will, because it is built to the limit of what surface chemistry can do. Everything beyond that ceiling belongs to medicine. That is precisely why the two stages are inseparable: the doctor lowers how much TMA is produced and escapes in the first place, and the surface takes care of what remains within its reach. Neither one, on its own, offers the full benefit.

When to see a doctor

A persistent fishy body odour warrants medical evaluation, particularly if it has been present since childhood, worsens after meals rich in fish, eggs, or beans, or fluctuates around menstruation. The appropriate first test is a urine measurement of the TMA to TMAO ratio, ideally after a standardised food challenge, arranged through a doctor.^[2][7]

If the odour appeared suddenly in adulthood, or is accompanied by other symptoms, a doctor can look for a secondary cause such as liver or kidney impairment, since correcting an underlying driver can resolve the odour in the acquired form.^[3][4] Do not begin a restrictive diet on your own, because choline is an essential nutrient and unsupervised restriction carries its own risks; let a clinician or dietitian guide it.^[2]

A doctor addresses the underlying source. The Volatile Control System addresses whatever component of the odour is manageable at the skin surface. If the VCS cannot fully resolve the odour, no other topical product will. What remains belongs to medicine.